Go Deep
Parabilis Medicines, Inc.
Parabilis Medicines, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,490 | -2.8 | 3.17 | 0.04 | 2,557.02 |
| Oct 2026 | 19,660 | -2.7 | 3.05 | 0.04 | 2,458.19 |
| Oct 2026 | 19,786 | -2.7 | 2.97 | 0.04 | 2,391.12 |
| Oct 2026 | 20,215 | -2.4 | 2.68 | 0.04 | 2,154.77 |
| Oct 2026 | 19,756 | -2.7 | 2.99 | 0.04 | 2,403.60 |
| Oct 2026 | 19,450 | -2.8 | 3.19 | 0.04 | 2,567.63 |
| Oct 2026 | 19,314 | -2.9 | 3.28 | 0.04 | 2,634.11 |
| Oct 2026 | 19,478 | -2.8 | 3.17 | 0.04 | 2,541.00 |
Parabilis Medicines, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|
| Revenue | 148,000.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -52,463,000.0 | -45,316,000.0 | -34,810,000.0 | -38,326,000.0 |
| EPS | -0.5 | -0.6 | -0.6 | -0.6 |
Parabilis Medicines, Inc. Revenue & Profit: Last 2 Years
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Net Profit | -145,889,000.0 | -117,914,000.0 |
| EPS | -1.8 | -2.0 |
Parabilis Medicines, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Total Assets | 80,820,000.0 | 149,253,000.0 |
| Total Liabilities | 97,344,000.0 | 92,814,000.0 |
| Total Equity | -16,524,000.0 | 56,439,000.0 |
Owes vs Owns
Parabilis Medicines, Inc. owed $0.11 for every $1 it owned in Jun 2026, down from $0.62 in Dec 2024.
| Period | Jun 2026 | Dec 2025 | Dec 2024 |
|---|---|---|---|
| Owes vs Owns | 0.11× | 1.20× | 0.62× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Parabilis Medicines, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 34.3%Fixed assets (tangible) 57.0%Other assets 8.7%
How it's funded — Dec 2025
Short-term debt 13.4%Long-term debt 38.8%Payables 17.7%Other liabilities 30.0%
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Assets | ||
| Cash & short-term investments | 27.7 | 88.0 |
| Receivables | 0.0 | 0.4 |
| Inventory | 0.0 | 0.0 |
| Fixed assets (tangible) | 46.1 | 52.9 |
| Intangible assets | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 |
| Other assets | 7.0 | 8.0 |
| Liabilities & equity | ||
| Short-term debt | 13.1 | 2.5 |
| Long-term debt | 37.8 | 12.8 |
| Payables | 17.3 | 9.5 |
| Other liabilities | 29.2 | 68.0 |
| Shareholders' equity | -16.5 | 56.4 |
| Net tangible assets | -16.5 | 56.4 |
Parabilis Medicines, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 |
|---|---|---|
| Operating Activities | -123,713,000.0 | -103,613,000.0 |
| Investing Activities | 39,758,000.0 | 30,242,000.0 |
| Financing Activities | 64,382,000.0 | 78,068,000.0 |